[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2018-2023 Global Opioids Drug Consumption Market Report

June 2018 | 163 pages | ID: 23C5C27F4D7EN
LP Information

US$ 4,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Opioids Drug market for 2018-2023.

Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
The classification of Opioids Drug includes Oxycodone, Hydromorphone, Codeine, Fentanyl and Other, and the revenue proportion of Oxycodone in 2016 is about 33%, and the proportion is in decreasing trend from 2012 to 2016.
Opioids Drug is widely used for Pain Relief, Anesthesia and Other. The most proportion of Opioids Drug is for Pain Relief, and the proportion in 2016 is about 66.5%.
North America is the largest supplier of Opioids Drug, with a production market share nearly 71% in 2016. Europe is the second largest supplier of Opioids Drug Media, enjoying production market share nearly 16% in 2016.
North America is the largest consumption place, with a consumption market share nearly 60.5 % in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 20%.
Market competition is not intense. Purdue Pharma, J&J, Teva, Mylan, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Over the next five years, LPI(LP Information) projects that Opioids Drug will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Opioids Drug market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:
  • Oxycodone
  • Hydromorphone
  • Codeine
  • Fentanyl
  • Other
Segmentation by application:
  • Pain Relief
  • Anesthesia
  • Other
This report also splits the market by region:
  • Americas
  • United States
  • Canada
  • Mexico
  • Brazil
  • APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Spain
  • Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
  • Purdue Pharma
  • J&J
  • Teva
  • Mylan
  • Depomed
  • INSYS
  • Endo
  • Pfizer
  • Hikma
  • Mallinckrodt
  • Pernix
  • Egalet
  • Vistapharm
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
  • To study and analyze the global Opioids Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
  • To understand the structure of Opioids Drug market by identifying its various subsegments.
  • Focuses on the key global Opioids Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  • To analyze the Opioids Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • To project the consumption of Opioids Drug submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Opioids Drug Consumption 2013-2023
  2.1.2 Opioids Drug Consumption CAGR by Region
2.2 Opioids Drug Segment by Type
  2.2.1 Oxycodone
  2.2.2 Hydromorphone
  2.2.3 Codeine
  2.2.4 Fentanyl
  2.2.5 Other
2.3 Opioids Drug Consumption by Type
  2.3.1 Global Opioids Drug Consumption Market Share by Type (2013-2018)
  2.3.2 Global Opioids Drug Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Opioids Drug Sale Price by Type (2013-2018)
2.4 Opioids Drug Segment by Application
  2.4.1 Pain Relief
  2.4.2 Anesthesia
  2.4.3 Other
2.5 Opioids Drug Consumption by Application
  2.5.1 Global Opioids Drug Consumption Market Share by Application (2013-2018)
  2.5.2 Global Opioids Drug Value and Market Share by Application (2013-2018)
  2.5.3 Global Opioids Drug Sale Price by Application (2013-2018)

3 GLOBAL OPIOIDS DRUG BY PLAYERS

3.1 Global Opioids Drug Sales Market Share by Players
  3.1.1 Global Opioids Drug Sales by Players (2016-2018)
  3.1.2 Global Opioids Drug Sales Market Share by Players (2016-2018)
3.2 Global Opioids Drug Revenue Market Share by Players
  3.2.1 Global Opioids Drug Revenue by Players (2016-2018)
  3.2.2 Global Opioids Drug Revenue Market Share by Players (2016-2018)
3.3 Global Opioids Drug Sale Price by Players
3.4 Global Opioids Drug Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Opioids Drug Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Opioids Drug Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 OPIOIDS DRUG BY REGIONS

4.1 Opioids Drug by Regions
  4.1.1 Global Opioids Drug Consumption by Regions
  4.1.2 Global Opioids Drug Value by Regions
4.2 Americas Opioids Drug Consumption Growth
4.3 APAC Opioids Drug Consumption Growth
4.4 Europe Opioids Drug Consumption Growth
4.5 Middle East & Africa Opioids Drug Consumption Growth

5 AMERICAS

5.1 Americas Opioids Drug Consumption by Countries
  5.1.1 Americas Opioids Drug Consumption by Countries (2013-2018)
  5.1.2 Americas Opioids Drug Value by Countries (2013-2018)
5.2 Americas Opioids Drug Consumption by Type
5.3 Americas Opioids Drug Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Opioids Drug Consumption by Countries
  6.1.1 APAC Opioids Drug Consumption by Countries (2013-2018)
  6.1.2 APAC Opioids Drug Value by Countries (2013-2018)
6.2 APAC Opioids Drug Consumption by Type
6.3 APAC Opioids Drug Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Opioids Drug by Countries
  7.1.1 Europe Opioids Drug Consumption by Countries (2013-2018)
  7.1.2 Europe Opioids Drug Value by Countries (2013-2018)
7.2 Europe Opioids Drug Consumption by Type
7.3 Europe Opioids Drug Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Opioids Drug by Countries
  8.1.1 Middle East & Africa Opioids Drug Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Opioids Drug Value by Countries (2013-2018)
8.2 Middle East & Africa Opioids Drug Consumption by Type
8.3 Middle East & Africa Opioids Drug Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Opioids Drug Distributors
10.3 Opioids Drug Customer

11 GLOBAL OPIOIDS DRUG MARKET FORECAST

11.1 Global Opioids Drug Consumption Forecast (2018-2023)
11.2 Global Opioids Drug Forecast by Regions
  11.2.1 Global Opioids Drug Forecast by Regions (2018-2023)
  11.2.2 Global Opioids Drug Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Opioids Drug Forecast by Type
11.8 Global Opioids Drug Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Purdue Pharma
  12.1.1 Company Details
  12.1.2 Opioids Drug Product Offered
  12.1.3 Purdue Pharma Opioids Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Purdue Pharma News
12.2 J&J
  12.2.1 Company Details
  12.2.2 Opioids Drug Product Offered
  12.2.3 J&J Opioids Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 J&J News
12.3 Teva
  12.3.1 Company Details
  12.3.2 Opioids Drug Product Offered
  12.3.3 Teva Opioids Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Teva News
12.4 Mylan
  12.4.1 Company Details
  12.4.2 Opioids Drug Product Offered
  12.4.3 Mylan Opioids Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Mylan News
12.5 Depomed
  12.5.1 Company Details
  12.5.2 Opioids Drug Product Offered
  12.5.3 Depomed Opioids Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Depomed News
12.6 INSYS
  12.6.1 Company Details
  12.6.2 Opioids Drug Product Offered
  12.6.3 INSYS Opioids Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 INSYS News
12.7 Endo
  12.7.1 Company Details
  12.7.2 Opioids Drug Product Offered
  12.7.3 Endo Opioids Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Endo News
12.8 Pfizer
  12.8.1 Company Details
  12.8.2 Opioids Drug Product Offered
  12.8.3 Pfizer Opioids Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Pfizer News
12.9 Hikma
  12.9.1 Company Details
  12.9.2 Opioids Drug Product Offered
  12.9.3 Hikma Opioids Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Hikma News
12.10 Mallinckrodt
  12.10.1 Company Details
  12.10.2 Opioids Drug Product Offered
  12.10.3 Mallinckrodt Opioids Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 Mallinckrodt News
12.11 Pernix
12.12 Egalet
12.13 Vistapharm

13 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES AND FIGURES

Figure Picture of Opioids Drug
Table Product Specifications of Opioids Drug
Figure Opioids Drug Report Years Considered
Figure Market Research Methodology
Figure Global Opioids Drug Consumption Growth Rate 2013-2023 (M Units)
Figure Global Opioids Drug Value Growth Rate 2013-2023 ($ Millions)
Table Opioids Drug Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Oxycodone
Table Major Players of Oxycodone
Figure Product Picture of Hydromorphone
Table Major Players of Hydromorphone
Figure Product Picture of Codeine
Table Major Players of Codeine
Figure Product Picture of Fentanyl
Table Major Players of Fentanyl
Figure Product Picture of Other
Table Major Players of Other
Table Global Consumption Sales by Type (2013-2018)
Table Global Opioids Drug Consumption Market Share by Type (2013-2018)
Figure Global Opioids Drug Consumption Market Share by Type (2013-2018)
Table Global Opioids Drug Revenue by Type (2013-2018) ($ million)
Table Global Opioids Drug Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Opioids Drug Value Market Share by Type (2013-2018)
Table Global Opioids Drug Sale Price by Type (2013-2018)
Figure Opioids Drug Consumed in Pain Relief
Figure Global Opioids Drug Market: Pain Relief (2013-2018) (M Units)
Figure Global Opioids Drug Market: Pain Relief (2013-2018) ($ Millions)
Figure Global Pain Relief YoY Growth ($ Millions)
Figure Opioids Drug Consumed in Anesthesia
Figure Global Opioids Drug Market: Anesthesia (2013-2018) (M Units)
Figure Global Opioids Drug Market: Anesthesia (2013-2018) ($ Millions)
Figure Global Anesthesia YoY Growth ($ Millions)
Figure Opioids Drug Consumed in Other
Figure Global Opioids Drug Market: Other (2013-2018) (M Units)
Figure Global Opioids Drug Market: Other (2013-2018) ($ Millions)
Figure Global Other YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Opioids Drug Consumption Market Share by Application (2013-2018)
Figure Global Opioids Drug Consumption Market Share by Application (2013-2018)
Table Global Opioids Drug Value by Application (2013-2018)
Table Global Opioids Drug Value Market Share by Application (2013-2018)
Figure Global Opioids Drug Value Market Share by Application (2013-2018)
Table Global Opioids Drug Sale Price by Application (2013-2018)
Table Global Opioids Drug Sales by Players (2016-2018) (M Units)
Table Global Opioids Drug Sales Market Share by Players (2016-2018)
Figure Global Opioids Drug Sales Market Share by Players in 2016
Figure Global Opioids Drug Sales Market Share by Players in 2017
Table Global Opioids Drug Revenue by Players (2016-2018) ($ Millions)
Table Global Opioids Drug Revenue Market Share by Players (2016-2018)
Figure Global Opioids Drug Revenue Market Share by Players in 2016
Figure Global Opioids Drug Revenue Market Share by Players in 2017
Table Global Opioids Drug Sale Price by Players (2016-2018)
Figure Global Opioids Drug Sale Price by Players in 2017
Table Global Opioids Drug Manufacturing Base Distribution and Sales Area by Players
Table Players Opioids Drug Products Offered
Table Opioids Drug Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Opioids Drug Consumption by Regions 2013-2018 (M Units)
Table Global Opioids Drug Consumption Market Share by Regions 2013-2018
Figure Global Opioids Drug Consumption Market Share by Regions 2013-2018
Table Global Opioids Drug Value by Regions 2013-2018 ($ Millions)
Table Global Opioids Drug Value Market Share by Regions 2013-2018
Figure Global Opioids Drug Value Market Share by Regions 2013-2018
Figure Americas Opioids Drug Consumption 2013-2018 (M Units)
Figure Americas Opioids Drug Value 2013-2018 ($ Millions)
Figure APAC Opioids Drug Consumption 2013-2018 (M Units)
Figure APAC Opioids Drug Value 2013-2018 ($ Millions)
Figure Europe Opioids Drug Consumption 2013-2018 (M Units)
Figure Europe Opioids Drug Value 2013-2018 ($ Millions)
Figure Middle East & Africa Opioids Drug Consumption 2013-2018 (M Units)
Figure Middle East & Africa Opioids Drug Value 2013-2018 ($ Millions)
Table Americas Opioids Drug Consumption by Countries (2013-2018) (M Units)
Table Americas Opioids Drug Consumption Market Share by Countries (2013-2018)
Figure Americas Opioids Drug Consumption Market Share by Countries in 2017
Table Americas Opioids Drug Value by Countries (2013-2018) ($ Millions)
Table Americas Opioids Drug Value Market Share by Countries (2013-2018)
Figure Americas Opioids Drug Value Market Share by Countries in 2017
Table Americas Opioids Drug Consumption by Type (2013-2018) (M Units)
Table Americas Opioids Drug Consumption Market Share by Type (2013-2018)
Figure Americas Opioids Drug Consumption Market Share by Type in 2017
Table Americas Opioids Drug Consumption by Application (2013-2018) (M Units)
Table Americas Opioids Drug Consumption Market Share by Application (2013-2018)
Figure Americas Opioids Drug Consumption Market Share by Application in 2017
Figure United States Opioids Drug Consumption Growth 2013-2018 (M Units)
Figure United States Opioids Drug Value Growth 2013-2018 ($ Millions)
Figure Canada Opioids Drug Consumption Growth 2013-2018 (M Units)
Figure Canada Opioids Drug Value Growth 2013-2018 ($ Millions)
Figure Mexico Opioids Drug Consumption Growth 2013-2018 (M Units)
Figure Mexico Opioids Drug Value Growth 2013-2018 ($ Millions)
Table APAC Opioids Drug Consumption by Countries (2013-2018) (M Units)
Table APAC Opioids Drug Consumption Market Share by Countries (2013-2018)
Figure APAC Opioids Drug Consumption Market Share by Countries in 2017
Table APAC Opioids Drug Value by Countries (2013-2018) ($ Millions)
Table APAC Opioids Drug Value Market Share by Countries (2013-2018)
Figure APAC Opioids Drug Value Market Share by Countries in 2017
Table APAC Opioids Drug Consumption by Type (2013-2018) (M Units)
Table APAC Opioids Drug Consumption Market Share by Type (2013-2018)
Figure APAC Opioids Drug Consumption Market Share by Type in 2017
Table APAC Opioids Drug Consumption by Application (2013-2018) (M Units)
Table APAC Opioids Drug Consumption Market Share by Application (2013-2018)
Figure APAC Opioids Drug Consumption Market Share by Application in 2017
Figure China Opioids Drug Consumption Growth 2013-2018 (M Units)
Figure China Opioids Drug Value Growth 2013-2018 ($ Millions)
Figure Japan Opioids Drug Consumption Growth 2013-2018 (M Units)
Figure Japan Opioids Drug Value Growth 2013-2018 ($ Millions)
Figure Korea Opioids Drug Consumption Growth 2013-2018 (M Units)
Figure Korea Opioids Drug Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Opioids Drug Consumption Growth 2013-2018 (M Units)
Figure Southeast Asia Opioids Drug Value Growth 2013-2018 ($ Millions)
Figure India Opioids Drug Consumption Growth 2013-2018 (M Units)
Figure India Opioids Drug Value Growth 2013-2018 ($ Millions)
Figure Australia Opioids Drug Consumption Growth 2013-2018 (M Units)
Figure Australia Opioids Drug Value Growth 2013-2018 ($ Millions)
Table Europe Opioids Drug Consumption by Countries (2013-2018) (M Units)
Table Europe Opioids Drug Consumption Market Share by Countries (2013-2018)
Figure Europe Opioids Drug Consumption Market Share by Countries in 2017
Table Europe Opioids Drug Value by Countries (2013-2018) ($ Millions)
Table Europe Opioids Drug Value Market Share by Countries (2013-2018)
Figure Europe Opioids Drug Value Market Share by Countries in 2017
Table Europe Opioids Drug Consumption by Type (2013-2018) (M Units)
Table Europe Opioids Drug Consumption Market Share by Type (2013-2018)
Figure Europe Opioids Drug Consumption Market Share by Type in 2017
Table Europe Opioids Drug Consumption by Application (2013-2018) (M Units)
Table Europe Opioids Drug Consumption Market Share by Application (2013-2018)
Figure Europe Opioids Drug Consumption Market Share by Application in 2017
Figure Germany Opioids Drug Consumption Growth 2013-2018 (M Units)
Figure Germany Opioids Drug Value Growth 2013-2018 ($ Millions)
Figure France Opioids Drug Consumption Growth 2013-2018 (M Units)
Figure France Opioids Drug Value Growth 2013-2018 ($ Millions)
Figure UK Opioids Drug Consumption Growth 2013-2018 (M Units)
Figure UK Opioids Drug Value Growth 2013-2018 ($ Millions)
Figure Italy Opioids Drug Consumption Growth 2013-2018 (M Units)
Figure Italy Opioids Drug Value Growth 2013-2018 ($ Millions)
Figure Russia Opioids Drug Consumption Growth 2013-2018 (M Units)
Figure Russia Opioids Drug Value Growth 2013-2018 ($ Millions)
Figure Spain Opioids Drug Consumption Growth 2013-2018 (M Units)
Figure Spain Opioids Drug Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Opioids Drug Consumption by Countries (2013-2018) (M Units)
Table Middle East & Africa Opioids Drug Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Opioids Drug Consumption Market Share by Countries in 2017
Table Middle East & Africa Opioids Drug Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Opioids Drug Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Opioids Drug Value Market Share by Countries in 2017
Table Middle East & Africa Opioids Drug Consumption by Type (2013-2018) (M Units)
Table Middle East & Africa Opioids Drug Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Opioids Drug Consumption Market Share by Type in 2017
Table Middle East & Africa Opioids Drug Consumption by Application (2013-2018) (M Units)
Table Middle East & Africa Opioids Drug Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Opioids Drug Consumption Market Share by Application in 2017
Figure Egypt Opioids Drug Consumption Growth 2013-2018 (M Units)
Figure Egypt Opioids Drug Value Growth 2013-2018 ($ Millions)
Figure South Africa Opioids Drug Consumption Growth 2013-2018 (M Units)
Figure South Africa Opioids Drug Value Growth 2013-2018 ($ Millions)
Figure Israel Opioids Drug Consumption Growth 2013-2018 (M Units)
Figure Israel Opioids Drug Value Growth 2013-2018 ($ Millions)
Figure Turkey Opioids Drug Consumption Growth 2013-2018 (M Units)
Figure Turkey Opioids Drug Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Opioids Drug Consumption Growth 2013-2018 (M Units)
Figure GCC Countries Opioids Drug Value Growth 2013-2018 ($ Millions)
Table Opioids Drug Distributors List
Table Opioids Drug Customer List
Figure Global Opioids Drug Consumption Growth Rate Forecast (2018-2023) (M Units)
Figure Global Opioids Drug Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Opioids Drug Consumption Forecast by Countries (2018-2023) (M Units)
Table Global Opioids Drug Consumption Market Forecast by Regions
Table Global Opioids Drug Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Opioids Drug Value Market Share Forecast by Regions
Figure Americas Opioids Drug Consumption 2018-2023 (M Units)
Figure Americas Opioids Drug Value 2018-2023 ($ Millions)
Figure APAC Opioids Drug Consumption 2018-2023 (M Units)
Figure APAC Opioids Drug Value 2018-2023 ($ Millions)
Figure Europe Opioids Drug Consumption 2018-2023 (M Units)
Figure Europe Opioids Drug Value 2018-2023 ($ Millions)
Figure Middle East & Africa Opioids Drug Consumption 2018-2023 (M Units)
Figure Middle East & Africa Opioids Drug Value 2018-2023 ($ Millions)
Figure United States Opioids Drug Consumption 2018-2023 (M Units)
Figure United States Opioids Drug Value 2018-2023 ($ Millions)
Figure Canada Opioids Drug Consumption 2018-2023 (M Units)
Figure Canada Opioids Drug Value 2018-2023 ($ Millions)
Figure Mexico Opioids Drug Consumption 2018-2023 (M Units)
Figure Mexico Opioids Drug Value 2018-2023 ($ Millions)
Figure Brazil Opioids Drug Consumption 2018-2023 (M Units)
Figure Brazil Opioids Drug Value 2018-2023 ($ Millions)
Figure China Opioids Drug Consumption 2018-2023 (M Units)
Figure China Opioids Drug Value 2018-2023 ($ Millions)
Figure Japan Opioids Drug Consumption 2018-2023 (M Units)
Figure Japan Opioids Drug Value 2018-2023 ($ Millions)
Figure Korea Opioids Drug Consumption 2018-2023 (M Units)
Figure Korea Opioids Drug Value 2018-2023 ($ Millions)
Figure Southeast Asia Opioids Drug Consumption 2018-2023 (M Units)
Figure Southeast Asia Opioids Drug Value 2018-2023 ($ Millions)
Figure India Opioids Drug Consumption 2018-2023 (M Units)
Figure India Opioids Drug Value 2018-2023 ($ Millions)
Figure Australia Opioids Drug Consumption 2018-2023 (M Units)
Figure Australia Opioids Drug Value 2018-2023 ($ Millions)
Figure Germany Opioids Drug Consumption 2018-2023 (M Units)
Figure Germany Opioids Drug Value 2018-2023 ($ Millions)
Figure France Opioids Drug Consumption 2018-2023 (M Units)
Figure France Opioids Drug Value 2018-2023 ($ Millions)
Figure UK Opioids Drug Consumption 2018-2023 (M Units)
Figure UK Opioids Drug Value 2018-2023 ($ Millions)
Figure Italy Opioids Drug Consumption 2018-2023 (M Units)
Figure Italy Opioids Drug Value 2018-2023 ($ Millions)
Figure Russia Opioids Drug Consumption 2018-2023 (M Units)
Figure Russia Opioids Drug Value 2018-2023 ($ Millions)
Figure Spain Opioids Drug Consumption 2018-2023 (M Units)
Figure Spain Opioids Drug Value 2018-2023 ($ Millions)
Figure Egypt Opioids Drug Consumption 2018-2023 (M Units)
Figure Egypt Opioids Drug Value 2018-2023 ($ Millions)
Figure South Africa Opioids Drug Consumption 2018-2023 (M Units)
Figure South Africa Opioids Drug Value 2018-2023 ($ Millions)
Figure Israel Opioids Drug Consumption 2018-2023 (M Units)
Figure Israel Opioids Drug Value 2018-2023 ($ Millions)
Figure Turkey Opioids Drug Consumption 2018-2023 (M Units)
Figure Turkey Opioids Drug Value 2018-2023 ($ Millions)
Figure GCC Countries Opioids Drug Consumption 2018-2023 (M Units)
Figure GCC Countries Opioids Drug Value 2018-2023 ($ Millions)
Table Global Opioids Drug Consumption Forecast by Type (2018-2023) (M Units)
Table Global Opioids Drug Consumption Market Share Forecast by Type (2018-2023)
Table Global Opioids Drug Value Forecast by Type (2018-2023) ($ Millions)
Table Global Opioids Drug Value Market Share Forecast by Type (2018-2023)
Table Global Opioids Drug Consumption Forecast by Application (2018-2023) (M Units)
Table Global Opioids Drug Consumption Market Share Forecast by Application (2018-2023)
Table Global Opioids Drug Value Forecast by Application (2018-2023) ($ Millions)
Table Global Opioids Drug Value Market Share Forecast by Application (2018-2023)
Table Purdue Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Purdue Pharma Opioids Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Purdue Pharma Opioids Drug Market Share (2016-2018)
Table J&J Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table J&J Opioids Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure J&J Opioids Drug Market Share (2016-2018)
Table Teva Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Opioids Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Teva Opioids Drug Market Share (2016-2018)
Table Mylan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mylan Opioids Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Mylan Opioids Drug Market Share (2016-2018)
Table Depomed Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Depomed Opioids Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Depomed Opioids Drug Market Share (2016-2018)
Table INSYS Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table INSYS Opioids Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure INSYS Opioids Drug Market Share (2016-2018)
Table Endo Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Endo Opioids Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Endo Opioids Drug Market Share (2016-2018)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Opioids Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Pfizer Opioids Drug Market Share (2016-2018)
Table Hikma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hikma Opioids Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Hikma Opioids Drug Market Share (2016-2018)
Table Mallinckrodt Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mallinckrodt Opioids Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Mallinckrodt Opioids Drug Market Share (2016-2018)
Table Pernix Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Egalet Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Vistapharm Basic Information, Manufacturing Base, Sales Area and Its Competitors


More Publications